Back to Market Feed

Product Information

OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN is a brand product labeled by Novo Nordisk, priced at $331.9436 per ML under NDC 00169477212. Its NADAC has been published 214 times since Jul 20, 2022.

FDA first approved this application on Dec 5, 2017.

OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN

semaglutide
$331.9436per ML

Strength

2.68 mg/mL

Manufacturer

Novo Nordisk

NDC

00169477212

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

SEMAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA209637

FDA Approved

12/5/2017

On Market Since

4/25/2022

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN has been published 214 times since Jul 20, 2022, and over the history we have for it it has risen 16.1%. The table below summarizes its recorded NADAC range and movement.

Current price$331.9436 per ML
All-time high$331.9747 (Jun 10, 2026)
All-time low$285.8467 (Jul 20, 2022)
52-week high$331.9747
52-week low$322.1802
Median price$311.7341
Average price$311.4343
Largest weekly change+4.9% (Jan 11, 2023)
Weeks tracked214
Tracking sinceJul 20, 2022

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.0%

1Y

+3.0%

3Y

+10.4%

5Y

N/A

All

+16.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the semaglutide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1616
per EA
RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1625
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1945
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0873
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8981
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1370
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7416
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8142
per ML
BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
per ML
TRULICITY 4.5 MG/0.5 ML PEN
Brand
00002318280•Eli Lilly and Company
$487.3750
per ML

Frequently asked questions

What is the NADAC price of OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN?

The current National Average Drug Acquisition Cost (NADAC) for OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN, manufactured by Novo Nordisk, is $331.9436 per ML (NDC 00169477212), effective Aug 19, 2026.

How has the price of OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN changed over time?

Over the history we have for it, the NADAC for OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN has risen 16.1%. It has been tracked across 214 weekly CMS publications since Jul 20, 2022.

What are the highest and lowest recorded NADAC prices for OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN?

Since Jul 20, 2022, the NADAC for OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN has ranged from a low of $285.8467 (Jul 20, 2022) to a high of $331.9747 (Jun 10, 2026), with a median of $311.7341 per ML.

Are there cheaper alternatives to OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN?

No other NADAC-published product currently shares the active ingredient and strength of OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN?

OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN (NDC 00169477212) is labeled by Novo Nordisk, and CMS classifies it as a brand product.